Shah Amit B. bought OTLC
June 22, 2026 · Form 4 insider transaction
Shah Amit B. bought 20,000 shares of Oncotelic Therapeutics, Inc. at $0.05 per share, a transaction worth $1.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$0.05
Total value
$1.0K
InsiderShah Amit B.
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 22, 2026
Filing dateJune 22, 2026
Shares owned after378,837
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On June 22, 2026, Amit Shah purchased 20,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.05.